Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Gas Gangrene
Welcome,
Profile
Billing
Logout
1 Company
1 Product
1 Product
0 Mechanisms of Action
0 Trials
6 News
||||
||||||
Privigen
(human immune globulin intravenous 10%) /
CSL Behring
Trial completion:
INSTINCT: Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
(clinicaltrials.gov) - Sep 30, 2016
P2
, N=100, Completed,
Sponsor: Anders Perner
Active, not recruiting --> Completed
|||
|||||||
Privigen
(human immune globulin intravenous 10%) /
CSL Behring
Enrollment closed:
INSTINCT: Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
(clinicaltrials.gov) - Mar 5, 2016
P2
, N=100, Active, not recruiting,
Sponsor: Anders Perner
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
||||||||||
Biomarker, Trial completion, Enrollment change, IO biomarker:
BIONEC: Biomarkers in Patients With Flesh-eating Bacterial Infections
(clinicaltrials.gov) - Feb 17, 2016
P=N/A
, N=169, Completed,
Sponsor: Ole Hyldegaard
Recruiting --> Active, not recruiting Recruiting --> Completed | N=114 --> 169
||||||||||
Biomarker, Trial primary completion date, IO biomarker:
BIONEC: Biomarkers in Patients With Flesh-eating Bacterial Infections
(clinicaltrials.gov) - Oct 22, 2015
P=N/A
, N=114, Recruiting,
Sponsor: Ole Hyldegaard
Recruiting --> Completed | N=114 --> 169 Trial primary completion date: Jul 2015 --> Feb 2016
||||||||||
Biomarker, IO biomarker:
BIONEC: Biomarkers in Patients With Flesh-eating Bacterial Infections
(clinicaltrials.gov) - Jul 3, 2014
P=N/A
, N=114, Recruiting,
Sponsor: Ole Hyldegaard
|||||
|||||
Privigen
(human immune globulin intravenous 10%) /
CSL Behring
New P2 trial:
INSTINCT: Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
(clinicaltrials.gov) - Apr 9, 2014
P2
, N=100, Recruiting,
Sponsor: Anders Perner